242 related articles for article (PubMed ID: 15018846)
1. Stem cells as a potential treatment of neurological disorders.
Tai YT; Svendsen CN
Curr Opin Pharmacol; 2004 Feb; 4(1):98-104. PubMed ID: 15018846
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered human neural stem cells for brain repair in neurological diseases.
Kim SU
Brain Dev; 2007 May; 29(4):193-201. PubMed ID: 17303360
[TBL] [Abstract][Full Text] [Related]
3. The potential of stem cell therapies for neurological diseases.
Schwartz PH
Expert Rev Neurother; 2006 Feb; 6(2):153-61. PubMed ID: 16466295
[TBL] [Abstract][Full Text] [Related]
4. The promise of stem cells for neural repair.
Miller RH
Brain Res; 2006 May; 1091(1):258-64. PubMed ID: 16563359
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-based cell therapy in neurological diseases: a review.
Kim SU; de Vellis J
J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
[TBL] [Abstract][Full Text] [Related]
6. Neural stem cells and their use as therapeutic tool in neurological disorders.
Pluchino S; Zanotti L; Deleidi M; Martino G
Brain Res Brain Res Rev; 2005 Apr; 48(2):211-9. PubMed ID: 15850660
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of stem cells in central nervous system regeneration.
Webber DJ; Minger SL
Curr Opin Investig Drugs; 2004 Jul; 5(7):714-9. PubMed ID: 15298066
[TBL] [Abstract][Full Text] [Related]
8. Stem cells for the treatment of neurological disorders.
Lindvall O; Kokaia Z
Nature; 2006 Jun; 441(7097):1094-6. PubMed ID: 16810245
[TBL] [Abstract][Full Text] [Related]
9. Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes.
van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ
Brain Res Rev; 2009 Jun; 61(1):1-13. PubMed ID: 19348860
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of stem cells in perinatal medicine.
Santner-Nanan B; Peek MJ; McCullagh P; Nanan R
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):102-7. PubMed ID: 15760308
[TBL] [Abstract][Full Text] [Related]
11. Stem cell transplantation for neurometabolic and neurodegenerative diseases.
Shihabuddin LS; Aubert I
Neuropharmacology; 2010 May; 58(6):845-54. PubMed ID: 20036262
[TBL] [Abstract][Full Text] [Related]
12. Stem cell therapy-present status.
Aejaz HM; Aleem AK; Parveen N; Khaja MN; Narusu ML; Habibullah CM
Transplant Proc; 2007 Apr; 39(3):694-9. PubMed ID: 17445575
[TBL] [Abstract][Full Text] [Related]
13. Progress and prospects: stem cells and neurological diseases.
Gögel S; Gubernator M; Minger SL
Gene Ther; 2011 Jan; 18(1):1-6. PubMed ID: 20882052
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of neural stem cells.
Martino G; Pluchino S
Nat Rev Neurosci; 2006 May; 7(5):395-406. PubMed ID: 16760919
[TBL] [Abstract][Full Text] [Related]
15. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage.
Mueller D; Shamblott MJ; Fox HE; Gearhart JD; Martin LJ
J Neurosci Res; 2005 Dec; 82(5):592-608. PubMed ID: 16247803
[TBL] [Abstract][Full Text] [Related]
16. Transplanted human embryonic stem cells as biological 'catalysts' for tissue repair and regeneration.
Heng BC; Liu H; Cao T
Med Hypotheses; 2005; 64(6):1085-8. PubMed ID: 15823689
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
Pluchino S; Martino G
J Neurol Sci; 2005 Jun; 233(1-2):117-9. PubMed ID: 15896808
[TBL] [Abstract][Full Text] [Related]
18. Routes of stem cell administration in the adult rodent.
Willing AE; Garbuzova-Davis S; Sanberg PR; Saporta S
Methods Mol Biol; 2008; 438():383-401. PubMed ID: 18369773
[TBL] [Abstract][Full Text] [Related]
19. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum.
Darsalia V; Kallur T; Kokaia Z
Eur J Neurosci; 2007 Aug; 26(3):605-14. PubMed ID: 17686040
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
